Epigenetic modulator inhibition overcomes temozolomide chemoresistance and antagonizes tumor recurrence of glioblastoma

Journal: Journal of Clinical Investigation

Published: 2020-10-05

DOI: 10.1172/jci127916

Affiliations: 7

Authors: 9

Go to article
Institutions Share
University of Southern California (USC), United States of America (USA) 0.65
Nanjing University of Aeronautics and Astronautics (NUAA), China 0.11
State Key Laboratory of Medicinal Chemical Biology (SKLMCB), NKU, China 0.09
Nankai University (NKU), China 0.09
Korea Research Institute of Chemical Technology (KRICT), South Korea 0.03
Chonnam National University, South Korea 0.03

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER